Suggested Topics within your search.
Showing 961 - 980 results of 4,859 for search 'RPAF~', query time: 2.87s Refine Results
  1. 961
    Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies

    Role of Peroxisome Proliferator-Activated Receptor Gamma and Its Ligands in the Treatment of Hematological Malignancies by Richard P. Phipps, <?layout cmd="newline"?> Patricia J. Sime, Steven H. Bernstein, Tatiana M. Garcia-Bates, Geniece M. Lehmann, Patricia J. Simpson-Haidaris

    Published 2008-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 962
    Systemic and Lung Inflammation and Oxidative Stress Associated With Behavioral Changes Induced by Inhaled Paraquat Are Ameliorated by Carvacrol

    Systemic and Lung Inflammation and Oxidative Stress Associated With Behavioral Changes Induced by Inhaled Paraquat Are Ameliorated by Carvacrol by Arghavan Memarzia, Fatemeh Amin, Amin Mokhtari-Zaer, Zohre Arab, Saeideh Saadat, Mahrokh Heydari, Zahra Ghasemi, Farzaneh Naghdi, Mahmoud Hosseini, Mohammad Hossein Boskabady

    Published 2024-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 963
    Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth

    Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth by Manuel Fresno, Cristina Cacheiro-Llaguno, Manuel D. Díaz-Muñoz, Raquel Grau, Miguel A. Iñiguez

    Published 2008-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 964
    PGC1α −1 Nucleosome Position and Splice Variant Expression and Cardiovascular Disease Risk in Overweight and Obese Individuals

    PGC1α −1 Nucleosome Position and Splice Variant Expression and Cardiovascular Disease Risk in Overweight and Obese Individuals by Tara M. Henagan, Laura K. Stewart, Laura A. Forney, Lauren M. Sparks, Neil Johannsen, Timothy S. Church

    Published 2014-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 965
    The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination

    The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination by Graham Skelhorne-Gross, Christopher J. B. Nicol

    Published 2012-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 966
    Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions

    Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions by Wang-Soo Lee, Jaetaek Kim

    Published 2015-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 967
    PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors

    PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors by Elisabetta Benedetti, Renato Galzio, Barbara D'Angelo, Maria Paola Cerù, Annamaria Cimini

    Published 2010-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 968
    PPARγ and Its Role in Cardiovascular Diseases

    PPARγ and Its Role in Cardiovascular Diseases by Mini Chandra, Sumitra Miriyala, Manikandan Panchatcharam

    Published 2017-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 969
    PPAR Research: Successful Launching and Promising Future

    PPAR Research: Successful Launching and Promising Future by Mostafa Z. Badr

    Published 2009-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 970
    Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells

    Inhibitory Effects of a Novel PPAR-γ Agonist MEKT1 on Pomc Expression/ACTH Secretion in AtT20 Cells by Rehana Parvin, Erika Noro, Akiko Saito-Hakoda, Hiroki Shimada, Susumu Suzuki, Kyoko Shimizu, Hiroyuki Miyachi, Atsushi Yokoyama, Akira Sugawara

    Published 2018-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 971
    Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism

    Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism by Michael L. Cunningham, Bradley J. Collins, Milton R. Hejtmancik, Ronald A. Herbert, Gregory S. Travlos, Molly K. Vallant, Matthew D. Stout

    Published 2010-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 972
    PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs

    PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs by Serena Vella, Pier Giulio Conaldi, Tullio Florio, Aldo Pagano

    Published 2016-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 973
    PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis

    PPARG Epigenetic Deregulation and Its Role in Colorectal Tumorigenesis by Lina Sabatino, Alessandra Fucci, Massimo Pancione, Vittorio Colantuoni

    Published 2012-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 974
    15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity

    15-Deoxy-γ12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPARγ and Reduction in NF-κB Activity by Kan Chen, Jingjing Li, Junshan Wang, Yujing Xia, Weiqi Dai, Fan Wang, Miao Shen, Ping Cheng, Yan Zhang, Chengfen Wang, Jing Yang, Rong Zhu, Huawei Zhang, Yuanyuan Zheng, Jie Lu, Zhuoyi Fan, Yingqun Zhou, Chuanyong Guo

    Published 2014-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 975
    Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy during Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway

    Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy during Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway by Ziqi Cheng, Chuanyong Guo

    Published 2021-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 976
    Screening for PPAR Responsive Regulatory Modules in Cancer

    Screening for PPAR Responsive Regulatory Modules in Cancer by Merja Heinäniemi, Carsten Carlberg

    Published 2008-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 977
    Virtual Screening as a Technique for PPAR Modulator Discovery

    Virtual Screening as a Technique for PPAR Modulator Discovery by Stephanie N. Lewis, Josep Bassaganya-Riera, David R. Bevan

    Published 2010-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 978
    PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance

    PPARgamma-Dependent Control of Renin Expression: Molecular Mechanisms and Pathophysiological Relevance by Vladimir T. Todorov

    Published 2013-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 979
    Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets

    Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets by Fatemeh Kazeminasab, Maryam Baharlooie, Kamran Ghaedi

    Published 2022-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 980
    Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice

    Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice by Haiping Wang, Jing Sun, Zhanjun Jia, Tianxin Yang, Liang Xu, Bing Zhao, Kezhou Yu, Rong Wang

    Published 2015-01-01
    “…PPAR Research…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: